Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Secura Bio Announces Poster Presentation Highlighting New COPIKTRA® (duvelisib) Data for the Treatment of Patients With Peripheral T-Cell Lymphoma and Other Advanced Hematologic Malignancies at the 2
-
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024
-
American Shared Hospital Services Announces Third Quarter 2024 Earnings Conference Call
-
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
-
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
-
Cellebrite Announces Third-Quarter 2024 Results
-
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
-
YHN Acquisition I Limited Announces the Separate Trading of its Ordinary Shares and Rights, Commencing November 8, 2024
-
WW International, Inc. Announces Third Quarter 2024 Results
-
Macerich Reports Third Quarter 2024 Results
-
Stella-Jones Announces Third Quarter Results and Updates 2023-2025 Financial Objectives
-
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
-
LENZ Therapeutics Reports Third Quarter 2024 Financial Results
-
ScottsMiracle-Gro Reports Fiscal 2024 Fourth Quarter and Full-Year Results
-
Stella-Jones Announces Normal Course Issuer Bid
-
OMNI-LITE INDUSTRIES REPORTS THIRD QUARTER AND YEAR-TO-DATE FISCAL 2024 RESULTS
-
Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
-
CECO Environmental Announces Upcoming Investor Conferences
-
Lantheus Reports Third Quarter 2024 Financial Results
-
Kaltura Announces Financial Results for Third Quarter 2024
-
Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
-
Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA
-
Employ Inc. Announces Promotion of Stephanie Manzelli to Chief Human Resources Officer
-
Immunocore reports third quarter financial results and provides a business update
-
Neumora Therapeutics to Participate in Upcoming Conferences in November
-
Eldorado Gold Announces Normal Course Issuer Bid
-
YieldMax™ ETFs Announces Distributions on MRNY (73.00%), FBY (55.50%), DIPS (54.67%), YMAX (36.43%), YMAG (56.63%) and Others
-
Brookfield Infrastructure Achieves Capital Recycling Target and Announces Third Quarter 2024 Results
-
Reliance, Inc. Announces Participation at the Baird 2024 Global Industrial Conference
-
The Macerich Company Announces CFO Change
-
AvidXchange Announces Third Quarter 2024 Financial Results
-
Hut 8 Announces Initial ASIC Fleet Upgrade
-
SFL - Third Quarter 2024 Results
-
Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024
-
Hyperscale Data Plans to Issue a $16.25 Million Stated Value Special Dividend of 10% Series E Cumulative Redeemable Perpetual Preferred Stock
-
Planet 13 Increases Focus on Immersive Entertainment and Lifestyle Branding, Adds Jillian Austin as National Head of Marketing Experiences
-
October 2024 Monthly Investor Update
-
Crawford United Corporation Announces Third Quarter 2024 Results
-
Enovis Announces Third Quarter 2024 Results
-
Linkage Global Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
LXP Industrial Trust Reports Third Quarter 2024 Results
-
Calfrac Reports Third Quarter 2024 Results with Record Financial Performance in Argentina
-
Katapult Delivers 10% Revenue Growth in the Third Quarter, Above Outlook
-
Enterome to Present New Clinical Data and Biomarker Findings for EO2463 at the 2024 American Society of Hematology (ASH) Annual Meeting
-
Norsk Hydro: Status share buyback program
-
Hydreight Technologies Inc. Ranks 9th in Deloitte’s Technology Fast 50 Program Winners for 2024
-
MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Dr. Friend Proposes the Potential for Non-Pharmacological Improvement of Sleep Disorders, Published in an International SCI-Level Journal
-
nesto Recognized Among Deloitte Fast 50 Winners for Second Consecutive Year


